Levin Capital Strategies’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
GAM
Levin Capital Strategies's PLSE Position: Q4 2023 in Review
Levin Capital Strategies sold out of Pulse Biosciences (PLSE) in Q4 2023, closing a stake of 19,939 shares — an estimated $80.4K sold.
Levin Capital Strategies first reported a position in PLSE in Q1 2017 and held it in 26 quarters. The position peaked at $472K in Q1 2021. 50 funds tracked by Wall St. Rank hold PLSE as of Q4 2023.
- Levin Capital Strategies reported no remaining Pulse Biosciences position as of Q4 2023 after selling out during the quarter.
- Levin Capital Strategies sold 19,939 Pulse Biosciences shares in Q4 2023, an estimated $80.4K.
- Levin Capital Strategies first reported a position in Pulse Biosciences in Q1 2017 and held it in 26 quarters.
- Levin Capital Strategies's Pulse Biosciences position peaked at $472K in Q1 2021.
- 50 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2023.
Based on Levin Capital Strategies's 13F filing for Q4 2023, filed 6 Feb 2024.